top
Search terms
Results 1 - 5 of 5 - ordered by :
Ejhf

Heart failure (HF) remains an important public health problem, which is increasing in incidence and prevalence. [...]the recent PARADIGM-HF study[2] identified the first new class of drugs for the ...

European Journal of Heart Failure, Gold, Michael R., van Veldhuisen, Dirk J., Mann, Douglas L.

Date : 01/02/2015 Item size : 81797 bytes
Ehjournal

See page 2577 for the editorial comment on this article (doi:10.1093/eurheartj/ehq307) Introduction Erythropoietin (EPO) is commonly known as an effective treatment for anaemia, partly caused by an ...

European Heart Journal, Voors, Adriaan A., Belonje, Anne M.S., Zijlstra, Felix, Hillege, Hans L., Anker, Stefan D., Slart, Riemer H.J.A., Tio, René A., van ‘t Hof, Arnoud, Jukema, J. Wouter, ...

Date : 01/11/2010 Item size : 280692 bytes
Ehjournal

See page 2577 for the editorial comment on this article (doi:10.1093/eurheartj/ehq307) Introduction Erythropoietin (EPO) is commonly known as an effective treatment for anaemia, partly caused by an ...

European Heart Journal, Voors, Adriaan A., Belonje, Anne M.S., Zijlstra, Felix, Hillege, Hans L., Anker, Stefan D., Slart, Riemer H.J.A., Tio, René A., van ‘t Hof, Arnoud, Jukema, J. Wouter, ...

Date : 01/11/2010
Ejhf

Heart failure (HF) remains an important public health problem, which is increasing in incidence and prevalence. [...]the recent PARADIGM-HF study[2] identified the first new class of drugs for the ...

European Journal of Heart Failure, Gold, Michael R., van Veldhuisen, Dirk J., Mann, Douglas L.

Date : 01/02/2015 Item size : 85129 bytes
Ehjournal

Therapeutic options for patients with breast cancer have improved, and many patients with early breast cancer receive adjuvant systemic therapy including anthracyclines, taxanes, trastuzumab, ...

European Heart Journal, van der Meer, Peter, Gietema, Jourik A., Suter, Thomas M., van Veldhuisen, Dirk J.

Date : 01/06/2016 Item size : 171114 bytes